GlassScriptPhysician profile
Lewis S Blumenthal
NPI 1750366209
$1,544.15
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $644 · 2020: $367 · 2021: $516 · 2022: $17.25.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.84 | 2019-2021 | |
| Therapeuticsmd, INC. | $134.93 | 2019-2021 | |
| Allergan, INC. | $104.69 | 2019-2020 | |
| Coopersurgical, INC. | $79.45 | 2019-2021 | |
| Avion Pharmaceuticals | $68.88 | 2020-2021 | |
| Hologic Sales and Service, LLC | $67.93 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $62.97 | 2019-2021 | |
| Exeltis, USA INC. | $57.09 | 2019-2021 | |
| Agile Therapeutics, INC. | $50.55 | 2021 | |
| Amag Pharmaceuticals, INC. | $50.42 | 2019-2020 | |
| Amgen INC. | $48.88 | 2019 | |
| Merck Sharp & Dohme LLC | $43.65 | 2020-2021 | |
| Myovant Sciences INC. | $39.97 | 2021 | |
| Lupin INC. | $35.70 | 2019 | |
| Vertical Pharmaceuticals, LLC | $31.02 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $27.41 | 2020 | |
| Dysis Medical, INC. | $23.79 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.91 | 2020 | |
| Novo Nordisk INC | $22.72 | 2019 | |
| Boston Scientific Corporation | $18.35 | 2019 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Blumenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.